ALK and non-small cell lung carcinoma: In non-small-cell lung cancer cells with emL4-ALK gene fusion, inhibition of SMYD2 expression or protein catalytic function leads to decreased levels of methylation and phosphorylation of EML4-AlK protein K1610, which inhibits cell growth [35].